The following is a summary of “GATA3 amplification is associated with high grade disease in non-invasive urothelial bladder cancer but unrelated to patient prognosis,” published in the February 2025 ...
During a live event, participating oncologists discuss the role of ctDNA and molecular testing in muscle-invasive bladder ...
Discover recent findings that highlight the potential for urinary DNA methylation testing to improve early detection and diagnosis of bladder cancer.
Findings indicate that the test demonstrated 89.2% sensitivity and 87.8% specificity for detecting high-grade or invasive ...
The study involved 226 patients with high-grade, clinically organ-confined bladder cancer who subsequently underwent radical ...
Among patients with low-grade, intermediate-risk NMIBC, UGN-102 generated robust, durable responses in an analysis of the ...
The approach requires balance, however. There is the risk of increased AEs, as well as financial toxicity. Friedlander shared ...
UGN-102 led to durable responses in low-grade, intermediate-risk bladder cancer, per phase 3 study findings at the 2025 ...
A new study suggests that a combination of radiation therapy and immune checkpoint inhibitors (ICIs) may offer a less ...
The Bladder Cancer Company, announces the presentation on February 14 of a new abstract with study results from its U.S. bladder cancer patient registry at the 2025 American Society of Clinical ...